Aν. Καθηγήτρια Ενδοκρινολογίας
  1.  M. Peppa-Patrikiou, M. Scordili, A. Antoniou, M. Giannaki, M. Dracopoulou, C. Dacou-Voutetakis. “Carotid atherosclerosis in adolescents and young adults with IDDM. Relation to urinary endothelin, albumin, free cortisol and other factors”. Diabetes Care 1998; 21 (6): 1004-1007
  2. M. Peppa-Patrikiou, M. Dracopoulou, C. Dacou-Voutetakis. “Urinary endothelin in adolescents and young adults with insulin dependent diabetes mellitus. Relation to urinary albumin, blood pressure and other factors”. Metabolism 1998; 47(11): 1408-1412
  3. C. Dacou-Voutetakis, M. Peppa-Patrikiou, M. Dracopoulou. “Urinary free cortisol and its nyctohemeral variation in adolescents and young adults with IDDM: Relation to endothelin 1 and indices of diabetic angiopathy”. Journal of Pediatric Endocrinology and Metabolism, 1998; 11(3): 437-445
  4. Ι. Vaindirlis, M. Peppa-Patrikiou, M. Dracopoulou, Ι. Μanoli, A. Voutetakis, C. Dacou-Voutetakis. “White coat or stress hypertension in adolescents: Increased values of urinary cortisol and endothelin”. Journal of Pediatrics 2000; 136 (3): 359-64
  5. M. Liacopoulou, Τ. Alifieraki, A. Katideniou, M. Peppa, M. Maniati, D. Tzikas, E. Hibbs, C. Dacou-Voutetakis. «Maternal expressed emotion and metabolic control of children and adolescents with diabetes mellitus». Psychotherapy and Psychosomatics 2001; 70(2):78-85
  6. H. Vlassara, W. Cai, J. Crandall, T. Goldberg, R. Oberstein, V. Dardaine, M. Peppa, E. Rayfield.  Inflammatory markers are induced by dietary glycotoxins: A pathway for accelerated atherosclerosis in diabetes.  Proc Natl Acad Sci 2002; 99(24):15596-601
  7. WJ. Cai, QD. Cao, L. Zhu, M. Peppa, C. He, H. Vlassara. Oxidative stress-inducing carbonyl compounds from common foods: Novel mediators of cellular dysfunction. Molecular Medicine 2002; 8(7):337-46
  8. M. Peppa, T. Goldberg, W. Cai, E. Rayfield, H. Vlassara. Glycotoxins: A missing link in the “Relationship of dietary fat and meat intake and risk of type 2 diabetes in men”. Diabetes Care, 2002; 25 (10): 1898-9
  9.  M. Peppa, J. Uribarri, H. Vlassara. Advanced glycoxidation: A new risk factor for cardiovascular disease? (Review). Cardiovascular Toxicology 2002; 2 (4) :275-287
  10. J. Uribarri, M. Peppa, W. Cai, T. Goldberg, M. Lu, C. He, H. Vlassara. Restriction of dietary glycotoxins markedly reduces AGE toxins in renal failure patients. J Am Soc Nephrol, 2003; 14(3): 728-731
  11. M. Peppa, C. He, M. Hattori, R. McEvoy, F. Zheng, H. Vlassara. Fetal or Neonatal Low-Glycotoxin Environment Prevents Autoimmune Diabetes in NOD Mice. Diabetes 2003; 52(6):1441-8
  12. J. Uribarri, M. Peppa, W. Cai, T. Goldberg, S. Baliga, M. Lu, J.A.Vassalotti, H. Vlassara. Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients.  Am J Kid Dis 2003; 42(3):532-8
  13.  M Peppa, Η. Brem, P. Ehrlich, J. Zhang, W. Cai, Z. Li, A. Croitoru, S. Thung, and H. Vlassara. Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice. Diabetes 2003; 52 (11): 2805-2813
  14. M. Peppa, J. Uribarri, H. Vlassara. Glucose, advanced glycation end products (AGE) and diabetic complications. Clin Diabetes 2003, 21(4):186-188, αναφορές n=40
  15. M. Peppa, J. Uribarri, W. Cai, M. Lu, H. Vlassara. Glycoxidation and inflammation in renal failure patients. Am J Kid Dis 2004; 43 (4):690-696
  16.  T. Goldberg, W. Cai, M. Peppa, V. Dardaine, BS. Baliga, J. Uribarri, H. Vlassara. Advanced glycoxidation end products in commonly consumed foods. J Am Diet Assoc 2004; 104(8):1287-91.
  17. W. Cai, JC He, L Zhu, M. Peppa, C Lu, J. Uribarri, H. Vlassara. High Levels of Dietary Advanced Glycation End Products Transform Low-Density Lipoprotein Into a Potent Redox-Sensitive Mitogen-Activated Protein Kinase Stimulant in Diabetic Patients. Circulation. 2004;110 (3):285-291
  18. Μ. Peppa, J..Uribarri, H. Vlassara. The role of advanced glycation end products in the development of atherosclerosis. (Review). Curr Diab Rep. 2004;4(1):31-6.
  19. G. Ioannidis, M. Peppa, P. Rontogianni, M. Callifronas, C. Papadimitriou, G. Chrysanthopoulou, L. Anthopoulos, M. Kesse, N. Thalassinos. Concurrence of microalbuminuria and retinopathy in combination with cardiovascular risk factors: reliable detection of asymptomatic coronary artery disease in type 2 diabetes. Hormones 2004; 3 (3):198-204
  20. J. Uribarri, W. Cai, O. Sandu, M. Peppa, T. Goldberg, H. Vlassara. Diet-derived advanced glycation end products are major contributors to the body’s AGE pool and induce inflammation in healthy subjects. Ann N.Y. Acad. Sci 2005, 1043: 461-466
  21. M. Peppa, H. Vlassara. Advanced glycation end products and diabetic complications. A General overview. Hormones 2005, 4 (1):28-37
  22. M. Peppa, H. Brem, W.Cai, J. Basgen, L. Zhu, M. Lu, C. Lu, J. Uribarri, H. Vlassara. Prevention and reversal of diabetic nephropathy in db/db mice treated with alagebrium (ALT-711). Am J Nephrol 2006: 26:430-455
  23. WJ. Cai, L. Zhu, H. Chen, J. Uribarri, M. Peppa. Association of advanced glycoxidation end products and inflammation markers with thrombosis of arteriovenous grafts in hemodialysis patients.  Am J Nephrol 2006;26:181-185
  24. J. Uribarri, WJ Cai, M. Peppa, S. Goodman, L Ferrrucci, G. Striker, H. Vlassara. Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. J Gerontol A Biol Sci Med Sci. 2007,62(4):427-33
  25. G. Dimitriadis, I. Maratou, E. Boutati, A. Kollias, C. Tsegka, M. Alevizaki, M. Peppa, SA Raptis, D. Hatjidakis. Insulin-like growth factor 1 increases the recruitment of GLUT4 and GLUT3 glucose transporters on cell surface in hyperthyroidism. European Journal of Endocrinology 2008: 158(3), 361-66
  26. M. Peppa, H. Boutati, S. Kamakari, V. Pikounis, G. Peros, G. Koutsodontis, V. Metaxa- Mariatou, T. Economopoulos, S. A. Raptis, D. Hadjidakis. Novel Germline Mutations of the MEN1 Gene in Greek Families with Multiple Endocrine Neoplasia Type 1. Clin Endocrinol (Oxf). 2009 ;70(1):75-81
  27. K. Saltiki, A. Cimponeriu, K. Lili, M. Peppa, E. Anastasiou, M. Alevizaki. Severity of coronary artery disease in postmenopausal diabetic women. Hormones 2008; 7 (2): 148-156
  28. Μ. Peppa, E. Boutati, S. Kamakari, V. Pikounis, G. Peros, I. Panayiotides, T. Economopoulos, SA Raptis, D. Hadjidakis. Multiple endocrine neoplasia type 2A in two families with the familial medullary thyroid carcinoma associated G533C mutation of the RET proto-oncogene. Eur J Endocrinol. 2008 ;159(6):767-71
  29. M. Peppa, SA Raptis. Advanced glycation end products and cardiovascular Disease. Current Diabetes Reviews 2008, 4 (2):92-100
  30. M. Peppa, J. Uribarri, H. Vlassara. “Aging and glycoxidant stress” Hormones 2008; 7 (2): 123-133
  31. E. Maratou, D. Hadjidakis, A. Kollias, K. Tsegka, M. Peppa, M. Alevizaki, P. Mitrou, V. Lambadiari, Boutati E, D. Nikzas, N. Tountas, T. Economopoulos, SA Raptis, G. Dimitriadis. Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. Eur J Endocrinol.2009; 160 (5):785-90
  32. M. Peppa, Ε. Brountzos, N. Economopoulos, E. Boutati, V. Pikounis, P. Patapis, T. Economopoulos, S. A. Raptis, D. Hadjidakis. Embolization as an alternative treatment of insulinoma in a patient with multiple endocrine neoplasia syndrome type 1. Cardiovasc Intervent Radiol. 2009 ;32(4):807-11
  33. M. Peppa, I. Ekonomidis, D. Hadjidakis, V. Pikounis, J Paraskevaidis, T. Economopoulos, SA Raptis, ST Kremastinos.  Dilated cardiomyopathy as the predominant feature of Cushing’s syndrome. American Journal of Medical Sciences 2009;  338(3):252-3
  34. M. Peppa, P. Stavroulakis, S.A. Raptis. Advanced Glycoxidation Products and Impaired Diabetic Wound Healing (Review). Wound Rep Reg 2009; 17(4): 461–472
  35. M. Peppa, G. Papaxoinis, D. Hadjidakis,  N. Xiros, SA Raptis,  T. Economopoulos, D. Hadjidakis. Case report: Panhypopituitarism due to metastases to the hypothalamus and the pituitary resulting from primary breast cancer.A case report and review of the literature. Clinical Breast Cancer 2009 ; 9 (4) : E4-7
  36. M. Peppa, V. Pikounis, G. Papaxoinis, A. Macheras, T. Economopoulos, S. A. Raptis, D. Hadjidakis. Adrenocortical carcinoma secreting cortisol, androgens and aldosterone: a case report. Cases Journal 2009;10(2):8951
  37. M. Peppa, S. Kamakari, E. Boutati, P. Nikolopoulos, C. Giatzakis, T. Economopoulos, D. Hadjidakis, S. A. Raptis. A novel germline mutation of the VHL gene in a Greek family with Von-Hippel Lindau disease : BMJ Case Rep. 2009;2009. pii: bcr02.2009.1574. Epub 2009 Aug 19.
  38. M. Peppa, E. Boutati, C. Koliaki, N. Papaefstathiou, E. Garoflos, T. Economopoulos, D. Hadjidakis, S.A. Raptis. Insulin resistance and metabolic syndrome in patients with non-functioning adrenal incidentalomas: A cause-effect relationship? Metabolism 2010; 59(10):1435-41
  39. E. Maratou, DJ. Hadjidakis, M. Peppa, M. Alevizaki, K Tsegka, V.  Lambadiari, P. Mitrou, E.  Boutati, A. Kollias, T. Economopoulos, SA  Raptis, G. Dimitriadis. Studies of insulin resistance in patients with clinical and subclinical hyperthyroidism. Eur J Endocrinol. 2010; 163(4):625-30
  40. M. Peppa, E. Karamitopoulou, P. Nikolopoulos, G. Peros, T. Economopoulos, S. A. Raptis, D. Hadjidakis. Large adrenal oncocytoma with uncertain malignant potential. a case report and review of the literature. Endocr Pract. 2010; 16(4):641-5
  41. M. Peppa, C. Koliaki, P. Nikolopoulos, S.A. Raptus. Skeletal muscle insulin resistance in endocrine disease. Journal of Biomedicine and Biotechnology, 2010; (doi:10.1155/2010/527850)
  42. M. Peppa, M. Dracopoulou-Vabouli, S. A. Raptis. Bilateral adrenal myelolipomas associated with 21-hydroxylase deficiency. Endoc Prac 2010; 16(3):525-6
  43. M. Peppa, C. Koliaki, S.A. Raptis. Adrenal Incidentalomas and cardiometabolic morbidity: an emerging association with serious clinical implications Journal of Intern Med 2010; 268 (6): 555-66
  44. M. Peppa, D. Vlahakos. Are we satisfied with the follow-up of hypertensive and chronic kidney disease patients in outpatient clinics? Hippokratia. 2011;15(Suppl 1):44-9.
  45. M. Peppa, R. Betsi, G. Dimitriadis. Lipid abnormalities and cardiometabolic risk in patients with overt and subclinical thyroid disease. J Lipids. 2011;2011:575840. Epub 2011 Jul 18. 11.
  46. M. Peppa, S.A. Raptis. Glycoxidation and Wound Healing in Diabetes: An Interesting Relationship Current Diabetes Reviews, 2011, 7, 416-425
  47. M. Peppa, Μ. Κrania, S.A. Raptis. Hypertension and other morbidities with Cushing’s syndrome associated with corticosteroids. A review. Journal of Integrated Blood Pressure Control 2011; 4:7-16
  48. P. Ferentinos, E. Rizos, A. Douzenis, A. Papadopoulou, C. Christodoulou, M. Peppa, L. Lykouras. Androgen insensitivity and liability to drug-induced extrapyramidal symptoms. Gender Medicine, 2011; 8(2): 156-60
  49. M. Peppa, P.Nikolopoulos, P. Korkolopoulou, D. Lapatsanis, G. Dimitriadis, D. Hadjidakis, S.A Raptis. Primary MALT thyroid lymphoma: A rare thyroid neoplasm of extrathyroid origin.  Journal of Rare Tumors 2011, 2012;
  50. Ε. Trakakis, G. Basios, M. Peppa, G. Simeonidis, G. Labos, M. Creatsa, M. Misailidou, E. Boutati, V. Vaggopoulos, P. Panagopoulos, G. Dimitriades, D. Kassanos. The prevalence of glucose metabolism abnormalities in Greek women with polycystic ovary syndrome. Gynecol Endocrinol. 2012 [Epub ahead of print]
  51. E. Tsigkaropoulou, M. Peppa, C. Zompola, E. Rizos, I. Xelioti, S. Chatziioannou, A.Filippopoulou, "Hypogonadism due to hyperprolactinemia and subsequent first episode of psychosis” Gender Medicine 2012;9(1):56-60
  52. M. Peppa, C. Koliaki, G. Dimitriadis. Body Composition as an Important determinant of Metabolic Syndrome in Postmenopausal Women Endocrine&Metabolic Syndrome” doi:10.4172/2161-1017. S1-00
  53. M. Peppa, C. Koliaki, A. Papaefstathiou, E. Garoflos, N. Katsilambros, S. A. Raptis, D. Hadjidakis, G. D. Dimitriadis. Body Composition Determinants of Metabolic Phenotypes of Obesity in Nonobese and Obese Postmenopausal Women. Obesity (Silver Spring). 2012, doi: 10.1002/oby.20227.
  54. M. Peppa, C. Koliaki, E. Boutati, E. Garoflos, A. Papaefstathiou, N. Siafakas, N. Katsilambros, S. A. Raptis, D. Hadjidakis, G.D. Dimitriadis. Association of Lean Body Mass with Cardiometabolic Risk Factors in Healthy Postmenopausal Women. Obesity (Silver Spring). 2013 doi: 10.1002/oby.20389.
  55. Μ.  Peppa, C. Koliaki, DI. Hadjidakis, E. Garoflos, A. Papaefstathiou, N. Katsilambros, SA. Raptis, GD. Dimitriadis. Regional fat distribution and cardiometabolic risk in healthy postmenopausal women. Eur J Intern Med 2013; 24(8): 824-31
  56. L. Kolilekas, E.Manali, M. Peppa, T. Chamogeorgakis, A. Papadopoulou, C. triantafyllidou, K. Kagouridis, D. Rontogianni, A. Karakatsani, S. Papiris. Usual interstitial pneumonia in a patient with celiac disease and polyglandular syndrome IIIA. Pneumon 2014; 2794):345-34932.
  57. Ν. Papadopoulou, C. Skevaki, M. Peppa, I. Kosteria, I. Papasotiriou, G. Chrousos, C. Kanaka-Gantenbein. NGAL, GDF-15 and YKL-40: Early markers of diabetic nephropathy in young patients with Type 1 diabetes mellitus: One year follow up. Hormones (Athens). 2015; 14(2):232-40.
  58. A. Hatzioannou, I. Kanistras, E. Mantzou, E. Anastasiou, H Vlassara, M. Peppa, P. Lymberi, M. Alevizaki. Effect of advanced glycation end products on human thyroglobulin’s antigenicity as identified by the use of pathological sera from patients with Hashimoto thyroiditis and Gestational diabetes mellitus.  Int J Endocrinol. 2015; 849615. doi: 10.1155/2015/849615
  59. D.Xirofotos, E. Trakakis, M. Peppa, C. Chrelias, P. Panagopoulos, C. Christodoulaki, D. Sioutis, D. Kassanos. The amount and duration of smoking is associated with aggravation of hormone and biochemical profile in women with PCOS. Gynecol Endocrinol. 2015; 28:1-4.
  60. E. Rizos, K. Tournikioti, E. Alevyzakis, M. Peppa, K. Papazaxos, G. Zorbas, I. Michopoulos, I. Liappas, C. Papageorgiou, A. Douzenis. Acute Necrotizing Pancreatitis Following Olanzapine Treatment and 759C/T Polymorphism of HTR2C Gene: A Case Report. In Vivo. 2015 09-10;29(5):529-531. G. Koukoulis, A. Melidonis, K. Milios, Mellita Investigators. Quality of Life of Insulin-Naïve People with Type 2 Diabetes Mellitus Inadequately Controlled on Oral Antidiabetic Drugs after the Addition of Insulin Glargine, in Every Day Clinical Practice in Greece.  J Diabetes Metab Disord Control 2015; 2(2): 00037
  61. D. Kaldrymidis, G. Papadakis, G. Tsakonas, P. Kaldrymidis, T. Flaskas, A. Seretis, E. Pantazi, I. Kostoglou-Athanassiou, M. Peppa, P. Roussou, E. Diamanti-Kandarakis.  High Incidence of Thyroid Cancer among Patients with Acromegaly. J BUON 2016; 21(4):989-993
  62. C. Stefanaki, M. Peppa, D. Boschiero, G.P. Chrousos. Healthy overweight/obese youth: Early Osteosarcopenic Obesity Features. Eur J Clin Invest. 2016 ;46(9):767-78.
  63. C. Stefanaki, F. Bacopoulou, M. Peppa. Prediabetes in adolescence – Trends, causes, effects, and screening.  US Endocrinology 2016; 12(2): 1-6